Multicenter phase II study of second-line cetuximab plus folinic acid/5-fluorouracil/irinotecan (FOLFIRI) in KRAS wild-type metastatic colorectal cancer: the FLIER study.
Year: 2014
Type: article
Study design: Clinical Trial
Source: PubMed
Institutions: Kansai Medical University, Kansai Medical University Medical Center, Yamaguchi University, Kansai Rosai Hospital, Nishinomiya Municipal Central Hospital, Sakai City Medical Center, Osaka Prefectural Medical Center, Tokai Central Hospital, Hokkaido University Hospital, Aichi Medical University Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2115594109
